Sorrento Therapeutics logo
Sorrento Therapeutics SRNE
$ 0.27 -29.58%

Quarterly report 2023-Q1
added 05-15-2023

report update icon

Sorrento Therapeutics Operating Cash Flow 2011-2024 | SRNE

Annual Operating Cash Flow Sorrento Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-282 M -160 M -173 M -112 M -99.2 M -70.9 M -42.1 M - -16.5 M -3.8 M -2.74 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.74 M -282 M -96.1 M

Quarterly Operating Cash Flow Sorrento Therapeutics

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-49.5 M - -226 M -164 M -83.4 M - -210 M -127 M -48.1 M - -119 M -76.1 M -38.6 M - -137 M -91.1 M -44.3 M - -66.8 M -46.1 M -24 M - -54.3 M - - - - - - - - - - - - - -9.12 M - -9.28 M -6.3 M -2.48 M - -2.47 M -1.47 M -798 K - -2.2 M -1.61 M -428 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-428 K -226 M -60.7 M